HomeInsightsMarket Capitalization

Market Capitalization of Suven Life Sciences Ltd

Market Capitalization of Suven Life Sciences Ltd

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

9.6 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 10, 2024

Image

Suven Life Sciences Ltd

NSE: SUVEN

MARKETCAP

₹ 2805.52 crore

Last updated on: Nov 08, 2024

Key Highlights

  • The Market Cap of Suven Life Sciences Ltd is ₹ 2805 crore as of 08 Nov 24.
  • The Market Cap of Suven Life Sciences Ltd changed from ₹ 3320 crore on March 2019 to ₹ 2174 crore on March 2024 . This represents a CAGR of -6.82% over 6 years. .
  • The Latest Trading Price of Suven Life Sciences Ltd is ₹ 128.65 as of 08 Nov 15:30.
  • The Dividend Payouts of Suven Life Sciences Ltd changed from ₹ 0.6 on Jul 23, 2015 to ₹ 1.5 on Feb 14, 2019 . This represents a CAGR of 16.50% over 6 years. .

Historical Market Cap of Suven Life Sciences Ltd

No data available

* All values are in crore

Company Fundamentals for Suven Life Sciences Ltd

No data available

Image

Suven Life Sciences Ltd

NSE: SUVEN

PRICE

₹ 128.65

-2.80 (-2.13%)

stock direction

Last updated on: Nov 08 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Suven Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Nov 2024128.65
07 Nov 2024131.45
06 Nov 2024133.75
05 Nov 2024129.35
04 Nov 2024127.1
01 Nov 2024129.5
31 Oct 2024125.8
30 Oct 2024123.75
29 Oct 2024118.05
28 Oct 2024121.4

SWOT Analysis Of Suven Life Sciences Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Suven Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Suven Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Suven Life Sciences Ltd

No data available

No data available

Historical P/E Ratio of Suven Life Sciences Ltd

No data available

* All values are in %

Historical Revenue of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Suven Life Sciences Ltd

No data available

* All values are in

About Suven Life Sciences Ltd

  • Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989.
  • The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
  • Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
  • Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

Suven Life Sciences Ltd News Hub

News

Suven Life Sciences announces board meeting date

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 Oct...

Read more

21 Oct 202417:47

News

Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr

Consolidated net sales slipped 73.42% year on year (YoY) to Rs 1.01 crore in the quarter e...

Read more

05 Aug 202414:00

News

Suven Life Sciences announces board meeting date

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 5 Augu...

Read more

30 Jul 202410:24

News

Suven Life Sciences to convene AGM

Suven Life Sciences announced that the 35th Annual General Meeting(AGM) of the company wil...

Read more

07 May 202412:58

News

Suven Life Sciences to announce Quarterly Result

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 6 May ...

Read more

29 Apr 202419:07

News

Suven Life Sciences to hold board meeting

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 30 Jan...

Read more

24 Jan 202413:53

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Suven Life Sciences Ltd Market Cap

What is the market cap of Suven Life Sciences Ltd?

As of November 10, 2024, Suven Life Sciences Ltd has a market capitalization of ₹2805.52, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Suven Life Sciences Ltd's market capitalization?

Suven Life Sciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Suven Life Sciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Suven Life Sciences Ltd's market capitalization change?

Suven Life Sciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*